Inhibition of neurogenic inflammation in the meninges by a non-peptide NK1 receptor antagonist, RP 67580
- 1 July 1993
- journal article
- research article
- Published by Elsevier in European Journal of Pharmacology
- Vol. 238 (2-3), 421-424
- https://doi.org/10.1016/0014-2999(93)90879-m
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- A non-peptide NK1-receptor antagonist, RP 67580, inhibits neurogenic inflammation postsynapticallyBritish Journal of Pharmacology, 1993
- Distribution of neurokinin B in rat spinal cord and peripheral tissues: Comparison with neurokinin A and substance P and effects of neonatal capsaicin treatmentNeuroscience, 1992
- RP 67580, a non-peptide substance P antagonist, inhibits neurogenic inflammation and possesses antinociceptive activities in rodentsNeuropeptides, 1992
- The non-peptide substance P antagonist CP-96,345. Cardiovascular effects unrelated to actions on substance P receptorsNeuropeptides, 1992
- RP 67580, a non-peptide substance P antagonist: Comparison with other antagonists and affinities in different animal speciesNeuropeptides, 1992
- Neurogenic versus vascular mechanisms of sumatriptan and ergot alkaloids in migraineTrends in Pharmacological Sciences, 1992
- The antimigraine drug, sumatriptan (GR43175), selectively blocks neurogenic plasma extravasation from blood vessels in dura materBritish Journal of Pharmacology, 1990
- Ergot alkaloids block neurogenic extravasation in dura mater: Proposed action in vascular headachesAnnals of Neurology, 1988
- Substance P as neurogenic mediator of antidromic vasodilation and neurogenic plasma extravasationNaunyn-Schmiedebergs Archiv für experimentelle Pathologie und Pharmakologie, 1979
- Experimental immunohistochemical studies on the localization and distribution of substance P in cat primary sensory neuronsBrain Research, 1975